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ABSTRACT Intracellular survival of Salmonella relies on the activity of proteins translocated 
into the host cell by type III secretion systems (T3SS). The protein kinase activity of the T3SS 
effector SteC is required for F-actin remodeling in host cells, although no SteC target has 
been identified so far. Here we show that expression of the N-terminal non-kinase domain of 
SteC down-regulates the mating and HOG pathways in Saccharomyces cerevisiae. Epistasis 
analyses using constitutively active components of these pathways indicate that SteC inhibits 
signaling at the level of the GTPase Cdc42. We demonstrate that SteC interacts through its 
N-terminal domain with the catalytic domain of Cdc24, the sole S. cerevisiae Cdc42 guanine 
nucleotide exchange factor (GEF). SteC also binds to the human Cdc24-like GEF protein 
Vav1. Moreover, expression of human Cdc42 suppresses growth inhibition caused by SteC. 
Of interest, the N-terminal SteC domain alters Cdc24 cellular localization, preventing its nu-
clear accumulation. These data reveal a novel functional domain within SteC, raising the pos-
sibility that this effector could also target GTPase function in mammalian cells. Our results 
also highlight the key role of the Cdc42 switch in yeast mating and HOG pathways and pro-
vide a new tool to study the functional consequences of Cdc24 localization.
INTRODUCTION
Salmonella are Gram-negative intracellular bacteria that cause dis-
eases ranging from gastroenteritis to typhoid fever in humans and 
represent a major health problem worldwide (Ohl and Miller, 2001). 
These bacteria use type III secretion systems (T3SS) to deliver >30 
Salmonella pathogenicity island (SPI)-1 and -2 effector proteins di-
rectly into the host cell cytosol (Galan and Wolf-Watz, 2006). These 
virulence factors enable the precise manipulation of key proteins 
for signaling and morphogenesis in the host. By these means, 
Salmonella cells induce their own internalization by nonphagocytic 
intestinal epithelial cells and are able to survive and replicate within 
this hostile environment. T3SS-1-delivered SPI-1 effectors are mainly 
required for bacterial entry into the nonphagocytic cells (Ly and 
Casanova, 2007). T3SS-2 is induced within host cells and delivers 
SPI-2-effectors important for the development of a modified pha-
gosome called the Salmonella-containing vacuole (SCV), necessary 
for intracellular survival and favoring systemic spread (Steele-
Mortimer, 2008). During systemic infection, macrophages represent 
an important site for replication of Salmonella, and T3SS-2 is es-
sential for survival and multiplication within these immune cells 
(Chakravortty et al., 2002). Furthermore, effectors secreted by both 
T3SS are involved in the modulation of inflammatory responses 
(McGhie et al., 2009). Either proinflammatory or anti-inflammatory 
effects have been reported for different effectors, reflecting the 
complexity of the manipulation of host cell machinery orchestrated 
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activated by the small Rho GTPase Cdc42. In addition, Ste50 serves 
as an adaptor that links the Cdc42–Ste20 kinase complex to effector 
kinase Ste11. Once phosphorylated, the MAPK Fus3 translocates to 
the nucleus and phosphorylates Ste12, which activates transcription 
of pheromone response genes. The MAPK Kss1 is also transiently 
activated upon pheromone stimulation independently of the scaf-
fold protein, Ste5. Some of the mating pathway components also 
participate in one of the two branches that lead to the activation of 
the MAPK Hog1. In the HOG pathway, Cdc42-dependent activation 
of Ste20 results in the sequential activation of the MAPKKK Ste11, 
the MAPKK Pbs2, and the MAPK Hog1. A number of distinct mo-
lecular mechanisms ensure that activated Ste11 does not transmit 
the signal to the MAPK Ste7 in response to a hyperosmotic shock, 
preventing spurious cross-talk between the HOG and mating path-
ways (Chen and Thorner, 2007).
In a previous report, we identified SteC in a genetic screen for 
Salmonella Typhimurium proteins that produce toxicity when over-
expressed in the yeast model system (Aleman et al., 2009). This pro-
tein was shown to be translocated into host cells in a T3SS-2–de-
pendent manner, which led to its designation as Salmonella 
translocated effector C (SteC; Geddes et al., 2005). SteC displays an 
incomplete but active catalytic protein kinase domain that is essen-
tial for SPI-2–dependent F-actin meshwork formation in host cells 
(Poh et al., 2008). In the interest of identifying the cellular targets of 
this protein, we conducted a molecular and functional characteriza-
tion of SteC in the model yeast S. cerevisiae. Here we show that the 
N-terminal region of SteC down-regulates the yeast MAPK mating 
pathway at the level of Cdc42. Binding experiments indicate that 
SteC targets both the yeast Cdc42 GEF Cdc24 and the human 
Cdc24-like protein Vav1. Therefore our data point to a role for SteC 
in the regulation of GTPase function in yeast, thereby laying the 
foundation for investigation of SteC activity in more complex mam-
malian systems.
RESULTS
SteC expression down-regulates signaling through the yeast 
mating pathway
SteC contains a region (spanning amino acids 230–280) displaying 
homology to protein kinases, with the closest similarity to the hu-
man RAF proto-oncogene serine/threonine kinase (Poh et al., 2008; 
Aleman et al., 2009). An activated N-terminally truncated version of 
the MAPKKK Raf1 has been shown to substitute for Ste11 in the 
yeast pheromone MAPK-mediated pathway (Irie et al., 1994). With 
the aim of identifying the cellular targets of this protein, we used S. 
cerevisiae as a model to determine whether SteC was able to inter-
fere with this pathway, by expressing SteC fused to glutathione S-
transferase (GST) under the control of the inducible promoter 
GAL1.
Initially, we tested the effect of SteC expression on MAPK mating 
pathway signaling by a reporter transcription assay in which we used 
the pheromone-inducible FUS1 promoter and lacZ (β-galactosidase) 
reporter gene. As shown in Figure 1A, expression of the bacterial 
effector greatly reduced the transcriptional response to pheromone, 
suggesting a negative regulatory effect on this pathway. Next we 
expressed SteC in MATα itc1Δ yeast cells, which display an auto-
crine constitutive stimulation of the mating pathway due to inap-
propriate secretion of a-factor (Figure 1B; Ruiz et al., 2003). In this 
case, we analyzed the phosphorylation status of the MAPKs Fus3 
and Kss1 using antibodies that detect the dually phosphorylated 
and thereby activated forms of MAPKs (Martin et al., 2000). We first 
confirmed the identity of the distinct bands detected by these 
antibodies by activating the mating pathway in mutants lacking the 
SCV biogenesis is an extremely dynamic process involving the 
formation of distinct tubular networks during host cell infection 
through extensive changes in intracellular membrane trafficking and 
actin cytoskeleton (Schroeder et al., 2011). F-actin assembles in the 
vicinity of the SCV in the so-called vacuole-associated actin poly-
merizations, resulting in a nest or meshwork around bacteria clusters 
(Meresse et al., 2001). The microtubule network and molecular mo-
tors also play an essential role in the formation of the membrane 
tubules called Salmonella-induced filaments in a process that in-
volves the highly conserved Rho GTPase molecular switches 
(Bakowski et al., 2008). Rho proteins play a key role in essential 
physiological processes such as signal transduction, membrane traf-
ficking, and cytoskeletal dynamics (Heasman and Ridley, 2008). 
Targeting of cellular Rho GTPases occurs by Salmonella effectors 
that display guanine nucleotide exchange factor (GEF) or GTPase-
activating protein (GAP) activities, mimicking the activity of mam-
malian counterparts and resulting in the modulation of the host cel-
lular cytoskeleton and mitogen-activated protein kinase (MAPK) 
pathways that operate downstream. Effector proteins that post-
translationally modify either Rho GTPases or their GEFs and GAPs 
also have been identified from distinct bacteria and shown to oper-
ate in the pathogenic process (Galan, 2009).
The ease of genetic manipulation, the availability of postgen-
omic tools, the wealth of biological knowledge, and the conserva-
tion of most cellular processes affected during bacterial infection in 
Saccharomyces cerevisiae have led to the emergence of this yeast 
as a very useful model for the study of bacterial virulence proteins 
(Rodríguez-Pachón et al., 2002; Valdivia, 2004; Aleman et al., 2005; 
Rodriguez-Escudero et al., 2005). S. cerevisiae has six Rho GTPases, 
named Rho1–5 and Cdc42. Cdc42 plays a key role in the establish-
ment of polarized growth by regulating the organization of the actin 
cytoskeleton. Cdc24 is the sole GEF controlling Cdc42 activity 
(Perez and Rincon, 2010). Moreover, Cdc24 seems to be essential 
for the localization of Cdc42 at the presumptive bud site on the 
plasma membrane and therefore for polarity establishment (Howell 
and Lew, 2012). This yeast also possesses five distinct signaling 
pathways involved in mating, pseudohyphal/invasive growth, cell 
wall integrity (CWI), osmoregulation, and ascospore formation, me-
diated by MAPKs Fus3, Kss1, Slt2, Hog1, and Smk1, respectively 
(Chen and Thorner, 2007). Fus3 and Kss1 are orthologues to mam-
malian extracellular signal-regulated kinase (ERK) 1/2, and Hog1 is 
orthologous to p38 (Caffrey et al., 1999). The mammalian MAPK 
closest to Slt2 is ERK5 (Truman et al., 2006). These MAPKs contain a 
highly conserved T-X-Y motif in the kinase activation loop in which 
both threonine and tyrosine residues must be phosphorylated to 
achieve kinase activation (Raman et al., 2007).
The yeast mating pathway is one of the best-understood signal-
ing routes in eukaryotes, and its study has produced important ad-
vances in elucidating components and mechanisms participating in 
MAPK signaling (Dohlman and Slessareva, 2006). This pathway is 
activated by binding of the mating pheromone to a cell surface re-
ceptor, which causes the dissociation of the heterotrimeric G-protein 
into Gα subunit (Gpa1) and the Gβγ dimer (Ste4–Ste18) complex. 
The GAP function of the RGS protein Sst2 promotes the reassocia-
tion of Gpa1 with Ste4–Ste18, eventually contributing to pathway 
adaptation and recovery. On dissociation of the G-protein, the Gβγ 
dimer helps to recruit the scaffold protein Ste5 to the plasma mem-
brane, in complex with the MAPK kinase kinase (MAPKKK) Ste11, 
the MAPKK Ste7, and the MAPK Fus3, which phosphorylate one 
another in sequence. Activation of the first kinase of the cascade, 
Ste11, takes place at the plasma membrane through phosphoryla-
tion by its upstream activator, the PAK kinase Ste20, which in turn is 
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itc1Δ cells displaying aberrant morphology (Figure 1C) nor resulted 
in a decrease of Fus3 and Kss1 phosphorylation after pheromone 
stimulation (Figure 1D). The shorter SteC287-457 construct, which ex-
cludes the kinase region, did not result in signaling inhibition. In 
contrast, expression of the N-terminal fragment of SteC, either bear-
ing (SteC1-286) or lacking (SteC1-229) the kinase region, led to a re-
duced pathway output (Figure 1, C and D). A similar inhibitory effect 
was obtained when expressing a version of SteC in which amino 
acids 236–256 were deleted and thus just lacking the kinase do-
main. Of interest, expression of either a shorter N-terminal fragment 
of SteC (SteC1-156) or SteC lacking these first 156 amino acids did not 
alter signaling (Figure 1D). We also observed that phosphorylation 
of Kss1 increased its electrophoretic mobility. Accordingly, disap-
pearance of the faster Kss1 band only occurred in samples from cells 
expressing full-length SteC or SteC fragments with inhibitory activity 
targeted MAPKs (Supplemental Figure S1). As observed in Figure 
1B, the expression of GST-SteC resulted in a drastic reduction of the 
amount of phospho-Kss1 and phospho-Fus3 compared with control 
cells expressing GST. SteC also reduced the aberrant cell morphol-
ogy of MATα itc1Δ yeast cells, which resemble the polarized mating 
projection of cells responding to pheromone. These results clearly 
indicate that SteC negatively regulates the yeast mating pathway 
upstream of the MAPKs.
To establish the domain of SteC responsible for this inhibitory 
effect on signaling, we constructed a series of plasmids expressing 
distinct regions of SteC as GST fusions under the GAL1 promoter 
(Figure 1C). Western blotting analysis confirmed that all these SteC-
derived proteins were correctly expressed (Figure 1D). Galactose-
dependent production of the C-terminal domain of SteC (SteC230-457) 
including the kinase region neither reduced the percentage of MATα 
FIGURE 1: SteC inhibits signaling through the yeast pheromone response pathway. (A) Left, scheme illustrating 
pheromone stimulation of the mating pathway that results in Fus3 and Kss1 MAPK phosphorylation and Ste12-mediated 
FUS1 transcriptional activation. Right, wild-type YPH499 cells bearing pEG(KG) or pEG(KG)-SteC plasmids, expressing 
GST or GST-SteC respectively, were transformed with the plasmid pRS423-FUS1-lacZ, containing the pheromone-
inducible FUS1 promoter and lacZ reporter gene. Cells were grown to mid–log phase in raffinose-based medium, with 
galactose added for a final 2% for 4 h, and then treated with the indicated concentration of α-factor for additional 
90 min. β-Galactosidase activity was expressed as arbitrary fluorescence units. Data shown are the average of three 
independent experiments performed in triplicate. Error bars indicate standard deviations (SD). (B) Left, scheme 
illustrating how MATα itc1Δ yeast cells produce a-factor, leading to autocrine stimulation of the mating pathway. Middle, 
Western blotting analysis of cell extracts from the Y04500 MATα itc1Δ mutant strain transformed with the empty vector 
pEG-(KG) or pEG-(KG)-SteC, expressing GST or GST-SteC, respectively. Cells were grown as in A. Protein extracts were 
prepared, and the levels of phospho-Fus3 or phospho-Kss1, GST or GST fusions, and actin as loading control were 
detected by immunoblot analysis with anti–phospho-p44/42, anti-GST, and anti-actin antibodies, respectively. Right, 
DIC photographs showing the cell morphology of representative Y04500 MATα itc1Δ cells as in the middle. Bars, 5 μm. 
(C) Left, a schematic representation of the expressed fragments of SteC. The SteC region containing protein kinase 
subdomains is shown in gray, and the region showing similarity to RGS domains is indicated as white boxes. Right, 
percentage of cells displaying aberrant morphology from cultures of Y04500 MATα itc1Δ yeast cells expressing the 
indicated GST-tagged SteC fragments from pEG-(KG)–derived plasmids. Cells were observed 6 h after induction in 
galactose. Data are means of three experiments, and at least 100 cells were counted in each experiment. Error bars 
correspond to the SD. (D) Western blotting analysis of cell extracts from similar transformants as in C. Cells were 
cultured in absence (–) or presence (+) of 3 μM of α-factor, and protein extracts were prepared and analyzed as in B. 
Fus3 and Kss1 were detected with anti-Fus3 and anti-Kss1 antibodies, respectively. Reproducible results were obtained 
in different experiments, and selected images correspond to representative blots.
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first 156 amino acids was able to pull down Gpa1-Myc from yeast 
cell extracts (Figure 2A). We next used the reporter transcription as-
say based on the FUS1 promoter to analyze the effect of expressing 
SteC in an sst2Δ mutant strain (Dohlman et al., 1995). As observed 
in Figure 2B, deletion of the RGS-coding gene SST2 resulted in in-
creased sensitivity (EC50) and maximum response to pheromone, as 
well as an increase in the basal activity of the pathway. Although 
overexpression of SteC reduced both basal signaling and maximum 
responsiveness of this mutant, it failed to restore the EC50 to wild-
type levels (Figure 2B), suggesting that SteC is acting by using a 
different mechanism than the RGS Sst2. Furthermore, deletion of 
GPA1 did not prevent the down-regulating activity of SteC on Fus3 
and Kss1 phosphorylation (Figure 2C), clearly indicating that SteC 
acts in a Gpa1-independent manner.
To map the position in which SteC was impinging on the phero-
mone signaling pathway, we investigated the effect of SteC on 
on the mating pathway. In sum, these data indicate that the N-termi-
nal region spanning the first 229 amino acids is necessary for the 
SteC-induced inhibitory effect on signaling through the mating 
pathway, which is independent of SteC kinase activity.
SteC acts upstream of the mating MAPK module and 
independently of the Gα subunit Gpa1
Our structural analysis within the SteC N-terminal region using the 
SMART domain search tool identified a region encompassing amino 
acids 18–156 with low similarity to Regulator of G Protein Signaling 
(RGS) domains. Given that a receptor-coupled heterotrimeric G pro-
tein participates in the yeast mating pathway (Figure 2A), this find-
ing suggested that SteC could act on the α subunit Gpa1 in a man-
ner similar to the RGS protein Sst2, which down-regulates the mating 
pathway by promoting the GTPase activity of Gpa1 (Apanovitch 
et al., 1998). Consistent with this hypothesis, GST-SteC through the 
FIGURE 2: SteC binds Gpa1 but acts in the mating pathway independently of both the Gα subunit and the MAPK 
module. (A) Left, main components that operate in the yeast mating pathway. Right, immunoblot analysis of the 
copurification of Gpa1-6Myc with the indicated GST-tagged SteC fragments. Transformants of the YPH499 (GPA1-6Myc) 
strain with the plasmids pEG(KG) (GST), pEG-(KG)-SteC (SteC), pEG-(KG)-SteC1-229 (1–229), pEG-(KG)-SteC1-156 (1–156), 
or pEG-(KG)-SteC157-457 (157–457) were grown to mid–log phase in raffinose-based selective medium and then galactose 
was added for a final 2% for an additional 6 h. Cell extracts (input) and GST complexes obtained by purification with 
glutathione-Sepharose (pull down) were analyzed by immunoblotting with anti-Myc and anti-GST antibodies. 
(B) Transcription activity in response to distinct α-factor concentrations was measured as indicated in Figure 1A in 
strains YPH499 (WT) and YDM400 (sst2Δ) bearing the plasmid pRS423-FUS1-lacZ and transformed with pEG(KG) or 
pEG(KG)-SteC plasmids. Data shown are the average of three independent experiments performed in triplicate. Error 
bars indicate standard deviations. (C) Western blotting analysis of cell extracts from BY4741 (WT) and BYgpa1 (gpa1Δ) 
strains transformed with the empty vector pEG-(KG) or pEG-(KG)-SteC expressing GST (–) or GST-SteC (SteC), 
respectively. Cells were cultured and cell extracts analyzed as in Figure 1B. (D) Western blotting analysis of cell extracts 
from YPH499 (WT) cells expressing GST (–) or GST-SteC (SteC) from pEG-(KG)–derived plasmids and transformed with 
empty vector pEG(KG)H (–) or plasmids pRS315-GAL-STE4, pEG(KG)H-cdc42G12V, and pRS425-ste11-4 in order to 
overproduce Ste4 or the corresponding hyperactive versions of Cdc42 and Ste11-4. In the case of cells bearing 
pEG(KG)-ste20ΔN, which overproduce the corresponding hyperactive version of Ste20, SteC was expressed from 
plasmid YCpLG-SteC. Cells were cultured and extracts were analyzed as in Figure 1B. (E) Western blotting analysis 
of cells extracts from YPH499 (WT) cells expressing GST (–) or GST-SteC (SteC) from pEG-(KG)–derived plasmids 
and transformed with empty vector pRS316GAL or plasmid pGFP-G-STE5, pG-STE5-CTM, pT-G-STE11-Cpr, 
or pCUGF-STE5Q59L. Cells were cultured and extracts were processed and analyzed as in Figure 1B.
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induced activation of the pheromone MAPK cascade in a process 
that is dependent on the Cdc42 node but independent of other 
components of the mating pathway (Figure 3A). As observed in 
Figure 3B, overexpression of SteC reduces the NaCl-induced phos-
phorylation of mating MAPKs in a hog1Δ strain, suggesting that 
MAPK phosphorylation in strains in which the pathway was constitu-
tively activated from distinct points of the signaling cascade, namely 
by overexpression of the G protein β subunit Ste4 (Cole et al., 1990), 
the GTP-bound Cdc42G12V version (Andersson et al., 2004), an N-
terminally truncated version of Ste20 lacking the kinase-inhibitory 
CRIB domain (Ste20ΔN; Ramer and Davis, 1993; Martin et al., 1997), 
or the hyperactive MAPKKK version Ste11-4 (Stevenson et al., 1992). 
As shown in Figure 2D, SteC reduced signaling resulting from over-
expression of Ste4, confirming that SteC targets elements down-
stream the G protein α subunit. In contrast, SteC did not inhibit 
signaling in cells producing either Cdc42G12V or Ste20ΔN. These re-
sults indicate that SteC is not acting on the Ste11-Ste7-Fus3/Kss1 
MAPK cascade but instead on one of the upstream components. 
The weak SteC-induced reduction of signaling observed when ex-
pressing Ste11-4 is compatible with this model because Ste11-4 is 
still regulated by phosphorylation and therefore is able to transmit 
signaling from upstream elements (Drogen et al., 2000). The lack of 
effect on the Ste20ΔN-induced activation of the pathway suggests 
that SteC is not directly affecting Ste20 kinase activity. On the basis 
of these data, SteC is likely acting on one of the early steps of the 
mating pathway, for example, by interfering with either the Ste5-
dependent recruitment of the kinase cascade to the plasma mem-
brane or the Cdc42-promoted Ste20 activation.
To test the first possibility, we analyzed the effect of SteC overex-
pression on the constitutive activation caused by artificial targeting 
of the Ste5 scaffold or the Ste11 MAPKKK to the plasma membrane, 
which occurs in a heterotrimeric G protein–independent manner. To 
this end, we measured MAPK phosphorylation in cells expressing 
Ste5Q59L or Ste5-CTM versions localized at the membrane via an 
enhanced PM domain (Winters et al., 2005) or a foreign transmem-
brane domain (Pryciak and Huntress, 1998), respectively. We also 
used the Ste11-Cpr version targeted to the membrane via a preny-
lation/palmitoylation motif (Winters et al., 2005). In all cases, over-
production of SteC led to a reduction in MAPK activation (Figure 
2E), indicating that SteC is not interfering with the membrane re-
cruitment mediated by Ste5. Furthermore, these results rule out the 
possibility that SteC acts on the heterotrimeric G protein.
Next we checked whether the lack of other proteins involved in 
the initial steps of mating signaling, like the scaffold proteins Bem1 
and Far1 (Cote et al., 2011) and the Ste11 adaptor Ste50 (Truckses 
et al., 2006), affected the SteC-induced reduction of MAPK phos-
phorylation. Deletion of either BEM1 or FAR1 does not impede sig-
naling through the pathway. However, to analyze the effect of SteC 
in a ste50Δ mutant, cells carried a version of Ste5 (Ste5Q59L) that 
bypasses the requirement of Ste50 for mating signaling (Pryciak and 
Huntress, 1998; Winters et al., 2005). The inhibitory effect of SteC 
was observed in all cases (unpublished data), indicating that Bem1, 
Far1, and Ste50 are not targets for SteC.
As described, SteC inhibits pathway activation by pheromone 
but not by the constitutively active mutant Cdc42G12V. We also de-
termined the effect of SteC on cells expressing Cdc42G12V and 
treated with α-factor. Pheromone stimulation strongly increases 
Cdc42G12V-mediated activation of the pathway (Supplemental 
Figure S2). However, SteC expression was also unable to reduce 
MAPK phosphorylation under these conditions. These data suggest 
that SteC acts on Cdc42 function.
SteC prevents cross-talk between the HOG and pheromone 
response MAPK pathways in hog1Δ cells
It has been described that the MAPK Hog1 prevents cross-talk be-
tween the HOG and the pheromone response pathways (O’Rourke 
and Herskowitz, 1998). Thus the lack of Hog1 allows osmolarity-
FIGURE 3: SteC inhibits signaling through the Cdc42-dependent 
branch of the HOG pathway. (A) Scheme illustrating the main 
components that operate in the HOG pathway, including the 
Sln1-mediated (1) and Sho1-mediated (2) branches of the pathway 
and the cross-talk that takes place in the absence of Hog1 (3), leading 
to the spurious phosphorylation of mating MAPKs after high salt 
stress. (B) Western blotting analysis of cell extracts from the Y02724 
(hog1Δ) strain bearing the empty vector pEG-(KG) or pEG-(KG)-SteC, 
expressing GST or GST-SteC, respectively. Cells were grown to 
mid–log phase in raffinose-based selective medium, galactose was 
added for a final 2% for additional 6 h, and then cells were treated 
with 0.7 M NaCl for the indicated number of minutes. Protein extracts 
were prepared and analyzed as in Figure 1B. (C) Western blotting 
analysis of cell extracts from the TM141 (WT) and the TM257 (ssk2Δ 
ssk22Δ) strains bearing the empty vector pEG-(KG) or pEG-(KG)-SteC. 
Cells were cultured and extracts were processed and analyzed as in 
Figure 1B. The level of phospho-Hog1 was detected with anti–
phospho-p38 antibodies. Reproducible results were obtained in 
different experiments, and selected images correspond to 
representative blots.
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yeast or human hemagglutinin (HA)-tagged versions of Cdc42. The 
negative-dominant HsCdc42T17N (Feig, 1999) and the constitutively 
active HsCdc42G12V versions were also tested for their ability to bind 
SteC. No interaction was detected between SteC and any of these 
Cdc42 mutant proteins (Figure 5A and unpublished data). In con-
trast, the Salmonella mutant effector SopBR468A, known to interact 
with Cdc42 (Rodriguez-Escudero et al., 2011), pulled down human 
Cdc42 (Figure 5A). Both yeast two-hybrid and in vitro copurification 
assays with recombinant proteins expressed in Escherichia coli were 
also negative for interaction between SteC and Cdc42 (unpublished 
data).
Activation of yeast Cdc42 relies on its sole GEF protein, Cdc24. 
This GEF controls Cdc42 function, and therefore cdc24 mutants dis-
play the same phenotype as loss-of-function cdc42 mutant cells 
SteC is acting on a component shared by this cross-talk circuit and 
the mating pathway, possibly Cdc42. In accordance with these re-
sults, SteC was also able to reduce signaling through the HOG path-
way in response to high salt stress, as determined by a decrease in 
Hog1 phosphorylation (Figure 3C). This inhibitory effect of the bac-
terial effector was magnified in a strain lacking Ssk2/22. In this case 
one of the two inputs to the HOG pathway is missing, leaving only 
the HOG branch that is mediated by Cdc42 (Figure 3C). Taken to-
gether, these data strongly support the idea that SteC acts as a 
negative regulator of Cdc42-mediated signaling.
Cdc42 overexpression rescues SteC-induced inhibition 
of yeast growth
We previously showed that overexpression of either full-length or 
the N-terminal region of SteC in yeast cells leads to strong growth 
inhibition (Aleman et al., 2009). Therefore overexpression of the 
yeast SteC target is expected to relieve the lack of growth induced 
by this bacterial effector. Therefore, as a parallel and complemen-
tary approach to the epistasis analysis, we performed a genetic 
screen searching for suppressors of SteC toxicity. To this end, we 
transformed a GAL1-driven yeast cDNA library in cells overexpress-
ing steC under the same promoter and selected clones able to grow 
on galactose-inducing conditions. All positive clones shared the 
same DNA insert corresponding to yeast CDC42 (Figure 4A). Hu-
man Cdc42 is known to functionally replace its yeast orthologue 
(Munemitsu et al., 1990). Accordingly, overexpression from a differ-
ent GAL1-based plasmid of either yeast or human CDC42 also over-
came SteC toxicity (Figure 4A). Moreover, overexpression of yeast 
proteins related to Cdc42 function, such as Cdc43, Gic2, Rho3, Rsr1, 
and Ste20, which have been shown to compensate growth defects 
of distinct defective alleles of CDC42 (Kozminski et al., 2000, 2003), 
also alleviated SteC toxicity to a distinct extent (Supplemental Fig-
ure S3). Taken together, these results confirm that SteC-induced 
growth defects are caused by inhibition of Cdc42 function and are 
in agreement with the observed effects on the mating pathway.
To carry out cellular localization studies, we tagged SteC with 
green fluorescent protein (GFP). Fluorescence microscopy observa-
tions revealed that SteC-GFP predominantly showed peripheral lo-
calization, likely associated to the plasma membrane, but also colo-
calized with the marker FM4-64 that stains vacuolar and endosome 
membranes (Vida and Emr, 1995; Figure 4B). SteC1-229 presented 
the same localization as the full-length SteC, whereas SteC157-457 
showed a cytoplasmic distribution in the cells (Figure 4C), indicating 
that the N-terminal part of the protein is responsible for membrane 
targeting. GFP-Cdc42 also localized associated to membranes ei-
ther in the presence or the absence of SteC (Figure 4C). Moreover, 
we analyzed the presence of phosphoinositides phosphatidylinosi-
tol 4,5-bisphosphate and phosphatidylinositol 4-phosphate in yeast 
cells overexpressing SteC. These lipids are important for recruit-
ment of proteins that contain phosphoinositide-binding domains 
(Strahl and Thorner, 2007) and play a role in Cdc42 functionality 
(Yakir-Tamang and Gerst, 2009). SteC expression did not alter the 
cellular distribution of these phosphoinositides, as detected by us-
ing specific fluorescent probes (Stefan et al., 2002; Supplemental 
Figure S4). These data ruled out that mislocalization of Cdc42 or 
phosphoinositides alteration is the cause of the Cdc42 functional 
defect induced by SteC.
SteC physically interacts with Cdc24, the sole GEF 
for Cdc42
To determine whether SteC binds Cdc42, we carried out copurifica-
tion experiments with yeast cells coexpressing GST-SteC and either 
FIGURE 4: (A) Growth on SD (glucose) and SG (galactose) plates of 
serial dilutions of wild-type YPH499 yeast cells harboring the 
following plasmids, as indicated: YCpLG (–), YCpLG-SteC (SteC), 
pEG(KG) (GST), pEG(KG)-SteC (GST-SteC), pYES2 (–), pYES2-Cdc42-L 
(Cdc42-L), BG1805-Cdc42 (ScCdc42), and pYES2-HsCdc42 (HsCdc42), 
and therefore expressing under the control of the GAL1 promoter the 
corresponding proteins on galactose-based medium. (B) DIC and 
fluorescence microscopy photographs showing the cell morphology 
(Nomarski), SteC-GFP localization, and internal membrane localization 
(FM4-64) of YPH499 strain harboring the plasmid pGFP-CFUS-SteC 
expressing SteC-GFP. Cells were grown to mid–log phase in complete 
SD medium, washed, and then transferred to SD medium lacking 
methionine for 6 h and then treated with the vacuolar–membrane 
staining FM464. Bars, 5 μm. (C) Top, fluorescence microscopy 
photographs showing the in vivo localization of SteC1-229 and 
SteC1-157. YPH499 cells transformed with either pGFP-CFUS-SteC1-229 
or pGFP-CFUS-SteC1-157 were grown to mid–log phase in complete 
SD medium and transferred to a SD medium lacking methionine for 
6 h. Bottom, fluorescence microscopy photographs showing the in 
vivo localization of GFP-Cdc42 in cells expressing GST or GST-SteC, as 
indicated. YPH499 cells bearing pRS415-GFPCDC42 and pEG-KG or 
pEG-KG-SteC were grown to mid–log phase in raffinose-based 
selective medium lacking methionine, and then galactose was added 
for a final 2% for additional 6 h. Bars, 5 μm.
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region of SteC interacts with Cdc24, likely resulting in the inhibition 
of Cdc42 function.
SteC binds to Schizosaccharomyces pombe and human 
Cdc24 homologues
The use of the yeast model led us to identify Cdc24 as a target of 
SteC. Then we wanted to know whether SteC was able to bind 
similar GEFs from other organisms, including human, the natural 
host of Salmonella. We first tested interaction with Schizosaccha-
romyces pombe Scd1, the Cdc42 GEF homologue to Cdc24 (Perez 
and Rincon, 2010), by copurification experiments using a HA-
tagged version of this protein. As shown in Figure 6A, E. coli–
produced recombinant GST-SteC was able to pull down HA-Scd1 
from S. pombe extracts. Therefore the ability of SteC to bind 
Cdc42 GEFs is extended to evolutionary distant yeast like the fis-
sion yeast S. pombe. Of interest, no binding of SteC to Rom1, a 
GEF for S. cerevisiae Rho1 GTPase, was observed (unpublished 
data). This is consistent with the lack of inhibitory effect of SteC on 
the cell integrity MAPK pathway mediated by Rho1 (Aleman et al., 
2009).
Like other Dbl-family GEFs (Rossman et al., 2005), S. cerevisiae 
Cdc24 has a catalytic Dbl homology (DH) domain responsible for 
the GEF activity. The fact that sequence similarity between Cdc24 
and Scd1 mainly occurs within their DH domains (31% identity) led 
us to examine whether SteC interacted with this domain of Cdc24. 
To this end, we looked at the ability of GST-SteC to pull down the 
DH domain of Cdc24 (Cdc24287-473) tagged to Myc. As shown in 
Figure 6B, both full-length Cdc24-Myc and Cdc24 (DH)-Myc copuri-
fied with GST-SteC. These results indicate that the SteC Salmonella 
effector is likely to target GEFs through binding to the catalytic DH 
domain.
Next we tested the interaction of SteC with Vav1, one of the 
members of the human Dbl family of Rho GEFs that displays signifi-
cant similarity at the catalytic DH domain to yeast Cdc24 (24% iden-
tity). Vav1 activates Cdc42, Rac1, and RhoA GTPases and is involved 
in key biological functions, including actin cytoskeleton reorganiza-
tion and activation of ERK and Jun N-terminal kinase, as well as 
development and activation of immune cells (Lazer and Katzav, 
2011). Copurification in vitro assays with recombinant E-coli–
produced proteins showed that both GST-SteC and GST-Cdc42, 
used as a positive control, were able to bind the polyhistidine 
(polyHis)-tagged DH domain of the human GEF Vav1 (Figure 6C). 
Moreover, the N-terminal fragment of SteC (SteC1-229) also pulled 
down the DH domain of Vav1. These results suggest that SteC bind-
ing to the DH domain of GEFs might interfere with the correspond-
ing Rho GTPase function in Salmonella-infected cells. Although the 
most plausible mechanism underlying this effect would be the inhi-
bition of the catalytic activity of the GEF, in vitro assays showed that 
neither GST-SteC nor GST-SteC1-229 altered the exchange ability of 
Vav1 toward Rac1, the GTPase to which Vav1 GEF activity is most 
effective (Rapley et al., 2008; Figure 6D).
SteC prevents nuclear localization of Cdc24
Our results suggested that SteC does not inhibit the catalytic activity 
of bound GEF. To investigate how this effector could be altering 
GEF function, we analyzed several known layers of regulation of 
Cdc24, namely phosphorylation, oligomerization, and spatial regu-
lation. The PAK kinase Cla4 has been shown to phosphorylate 
Cdc24, leading to a mobility shift in SDS–PAGE (Gulli et al., 2000; 
Bose et al., 2001). As shown in Figure 7A, SteC does not inhibit 
phosphorylation of Cdc24 caused by the expression of a constitu-
tively active version of Cla4 (Martin et al., 1997).
(Perez and Rincon, 2010). Thus SteC could be inhibiting Cdc42 
function by targeting its positive regulator. To test this, we analyzed 
binding of SteC to Cdc24. As shown in Figure 5B, interaction experi-
ments in yeast revealed that tandem affinity purification–tagged 
Cdc24 copurified with GST-SteC. Moreover, both E. coli–produced 
recombinant GST-SteC and Gst-SteC1-229 were also able to pull 
down Cdc24 (Figure 5B). These data evidenced that the N-terminal 
FIGURE 5: SteC interacts with the Cdc42 GEF Cdc24. (A) 
Copurification assays of HA-HsCdc42 with GST (–), GST-SteC (SteC), 
or GST-SopBR468A. Transformants of the YPH499 strain with plasmid 
pYES3HA-Cdc42 and pEG(KG) (–), pEG(KG)-SteC (SteC), or pEG(KG)-
SopBR468A (SigDR468A) were grown to mid–log phase in raffinose-based 
selective medium, and then galactose was added for a final 2% for an 
additional 6 h. Cell extracts (input) and GST complexes obtained by 
precipitation with glutathione-Sepharose (pull down) were analyzed 
by immunoblotting with anti-HA and anti-GST antibodies as indicated. 
(B) Copurification assays of Cdc24-TAP with, as indicated, either 
yeast- or E. coli–produced GST (–), GST-SteC (SteC), or GST-SteC1-229 
(SteC1-229). For yeast expression, transformants of the YPH499 strain 
with plasmid BG1805-Cdc24 and pEG(KG) (–), pEG(KG)-SteC (SteC), 
or pEG(KG)- SteC1-229 (SteC1-229) were grown to mid–log phase in 
raffinose-based selective medium, and then galactose was added for 
a final 2% for an additional 6 h. Cell extracts (input) and GST 
complexes obtained by precipitation with glutathione-Sepharose (pull 
down) were analyzed by immunoblotting with anti-TAP and anti-GST 
antibodies as indicated. For in vitro copurification assays of 
recombinant SteC, E. coli extracts containing GST, GST-SteC, or 
GST-SteC1-229 were incubated with yeast extracts containing Cdc24-
TAP and glutathione-Sepharose to pull down GST complexes. 
Immunodetection was performed using anti-TAP (top) and anti-GST 
(bottom) antibodies. Reproducible results were obtained in different 
experiments, and selected images correspond to representative blots.
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during G1 phase, the bud tip at S and G2–M 
phases, and the mother–daughter bud neck 
during M phase (Toenjes et al., 1999). To in-
vestigate whether SteC affects the localiza-
tion of this GEF, we examined GFP-Cdc24 
localization in cells expressing GST, GST-
SteC, or GST-SteC1-229. As expected, Cdc24 
localized to the nucleus in unbudded and 
small-budded control cells after 6 h of ga-
lactose-induced expression of GST (Figure 
7B). Remarkably, the expression of GST-SteC 
clearly reduced the percentage of cells with 
nuclear Cdc24 (to 15%, down from 32% in 
control GST-expressing cells). Nuclear 
Cdc24 was reduced further to just 1% of 
cells expressing the SteC N-terminal domain 
(Figure 7C). Western blotting analysis re-
vealed that the amount of GFP-Cdc24 was 
similar in cells expressing either GST or 
SteC-derived GST fusion proteins (Figure 
7D), indicating that the alteration of Cdc24 
nuclear localization was not due to degrada-
tion of the protein. Oligomerization regu-
lates subcellular localization of Cdc24 
(Mionnet et al., 2008). As observed in Figure 
7E, however, SteC did not alter the amount 
of Cdc24-HA bound to Myc-Cdc24 in yeast 
coimmunoprecipitation experiments, ruling 
out the inhibition of Cdc24 oligomerization 
as the mechanism underlying the observed 
localization defects.
As expected, after 6 h of galactose in-
duction, SteC- or SteC1-229-expressing cells 
became big and round, and thus it was not 
possible to follow Cdc24 localization at dif-
ferent cell-cycle stages. To overcome this 
limitation, we carried out a Cdc24 localiza-
tion analysis with cells after just 2 h of galac-
tose-induced expression of GST or SteC-
derived GST-fusion proteins, in which 
GFP-Cdc24 production was confirmed by 
Western blotting (Figure 7H). Consistent 
with data presented in Figure 7C, whereas 
a high percentage of control cells express-
ing GST showed Cdc24 in the nucleus at 
G1 or M phase, a reduction of nuclear 
Cdc24 was observed in cells expressing 
SteC. Expression of SteC1-229 completely 
prevented nuclear Cdc24 in cells at these 
stages (Figure 7, F and G). In addition, the 
percentage of cells displaying Cdc24 local-
ization at polarized growth sites was also 
reduced upon expression of either SteC or 
SteC1-229, although this effect was milder 
than that observed for nuclear Cdc24 local-
ization (Figure 7G). Taken together, these 
results indicate that Cdc24 localization is 
significantly altered by SteC expression.
DISCUSSION
More than 20 Salmonella proteins are known to be translocated by 
the T3SS-2 across the phagosomal membrane (Srikanth et al., 2011). 
It is also known that Cdc24 shuttles between the nucleus and 
sites of cell growth. Cdc24 accumulates in the nucleus during late M 
phase and early G1 phase but then localizes at the incipient bud site 
FIGURE 6: SteC binds S. pombe Scd1 and human Vav1 GEFs. (A) Copurification assays of 
HA-Scd1 with recombinant GST (–) or GST-SteC (SteC). E. coli extracts containing GST or 
GST-SteC were incubated with S. pombe extracts containing HA-Scd1 and glutathione-
Sepharose to pull down GST complexes. Immunodetection was performed using anti-HA (top) 
and anti-GST (bottom) antibodies. (B) Copurification assays of Myc-Cdc24 and Myc-tagged 
Cdc24287-473 (Cdc24(DH)) with GST (–) or GST-SteC (SteC). Transformants of the YPH499 strain 
with plasmid p414-3xmycCdc24Fl or p414-3xmycDH-3xmyc and pEG(KG) (–) or pEG-(KG)-SteC 
(SteC) were grown to mid–log phase in raffinose-based selective medium, and then galactose 
was added for a final 2% for an additional 6 h. Cell extracts (input) and GST complexes obtained 
by precipitation with glutathione-Sepharose (pull down) were analyzed by immunoblotting with 
anti-Myc and anti-GST antibodies as indicated. (C) Copurification assays of the DH domain of 
human Vav1 with recombinant GST (–), GST-SteC (SteC), GST-SteC1-229 (SteC1-229), or GST-Cdc42. 
E. coli extracts containing GST or GST-fused proteins were incubated with E. coli extracts 
containing His-tagged Vav1(DH) and glutathione-Sepharose to pull down GST complexes. 
Immunodetection was performed using anti-His (top) and anti-GST (bottom) antibodies. 
Reproducible results were obtained in different experiments, and selected images correspond 
to representative blots. (D) Purified SteC does not modulate the Vav1-catalyzed exchange of 
guanine nucleotides bound to Rac1. Top, purified Rac1 (400nM) was incubated with Bodipy FL 
GDP (80 nM) before addition (arrow) of Vav1 preincubated with indicated forms of SteC. Final 
concentrations of Vav1 and SteC were 5 and 50 nM, respectively. Bottom, purified Rac1 (400 
nM) preloaded with Bodipy FL GDP was incubated with excess GDP (20 μM) before addition 
(arrow) of Vav1 preincubated with indicated forms of SteC. Final concentrations of Vav1 and 
SteC were 10 and 100 nM, respectively.
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However, the specific roles of many of these 
effectors are far from being well understood. 
Unveiling their functions is hindered by the 
fact that bacterial effectors are often multi-
functional proteins with different activities 
able to target many processes of eukaryotic 
physiology. Moreover, different effectors 
may display overlapping effects and coop-
erate to promote specific alterations in the 
host cell (Galan, 2009). Such redundancy 
could account for the absence of virulence 
attenuation in animal models by bacteria 
lacking a specific effector, as occurs with 
SteC (Geddes et al., 2005; Poh et al., 2008). 
These constraints have prompted the use 
of alternative approaches to investigate 
the functional roles of secreted bacterial 
proteins.
Here, by exploiting the yeast model, 
we identified a novel activity of SteC as a 
negative regulator of the GTPase Cdc42. 
Several observations support this conclu-
sion: 1) overexpression of SteC specifically 
inhibits Cdc42-mediated MAPK pathways, 
2) epistasis analysis places SteC at the level 
of Cdc42 in the mating pathway, 3) overex-
pression of either S. cerevisiae or human 
Cdc42 is able to counteract yeast growth 
inhibition caused by SteC, 4) this growth 
rescue is also achieved by overexpressing 
yeast suppressor genes of cdc42 mutations, 
and 5) SteC displays a similar localization as 
Cdc42 in the yeast cell. A large body of work 
has shown that various bacterial effectors 
modulate the GTPase cycle either by acting 
as GEFs or GAPs (Orchard and Alto, 2012) 
FIGURE 7: SteC modifies Cdc24 localization and does not affect Cdc24 phosphorylation and 
oligomerization. (A) Western blotting analysis of cell extracts from YPH499 cells harboring 
plasmids p414-3xmycCdc24Fl and pEG(KG) (–) or pEG(KG)-cla4ΔN (Cla4ΔN) and cotransformed 
with pEG(KG)H (–) or pEG(KG)H-SteC (SteC). Cells were grown to mid–log phase in raffinose-
based selective medium, and then galactose was added for a final 2% for an additional 6 h. The 
3xmycCdc24 was detected with 9E10 antibodies, and anti-G6PDH was used to detect G6PDH 
as a loading control. (B) Fluorescence microscopy photographs showing in vivo localization of 
Cdc24 and colocalization with 4′,6-diamidino-2-phenylindole staining. YKT725 cells expressing 
GFP-tagged Cdc24 and transformed with pEG(KG) (GST), pEG(KG)-SteC (GST-SteC), or 
pEG(KG)- SteC1-229 (GST-SteC1-229) were cultured as in A. Samples were taken at 6 h for 
microscope analysis. Bars, 5 μm. 
(C) Percentage of cells from the same 
cultures used in B, showing nuclear Cdc24. 
(D) Western blotting analysis of GFP-Cdc24 
from the same cultures used in B, using 
anti-GFP and anti-GST antibodies. 
(E) RAY1773 cells expressing HA-tagged 
Cdc24 were cotransformed with p414-
3xmycCdc24Fl plasmid and pEG(KG)H (GST), 
pEG(KG)H-SteC (GST-SteC), or pEG(KG)
H-SteC1-229 (GST-SteC1-229) and cultured as in 
B. HA-tagged Cdc24 was 
immunoprecipitated from cell extracts, and 
bound Myc-Cdc24 was assayed by Western 
blotting. (F) Fluorescence microscopy 
photographs showing the in vivo localization 
of YKT725 cells cultured as in B but with 
samples taken at 2 h after galactose addition. 
Bars, 5 μm. (G) Percentage of cells showing 
nuclear (gray bars) or growth sites (bud tips 
or septa, white bars) localization of GFP-
Cdc24 at different stages of the cell cycle. 
The indicated transformants were cultured as 
in F. n > 100 cells for each strain and for each 
cell cycle stage. (H) Western blotting analysis 
of YKT725 cell extracts of cells showed in G.
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precursor form. Of interest, we found a putative caspase-3 recogni-
tion site, DXXD (spanning amino acids 205–208), located between 
the two functional regions of SteC. It is therefore tempting to specu-
late that this protein could be processed by proteolytic cleavage 
into two functionally independent effector peptides.
We identified SteC in a screen for Salmonella proteins that cause 
toxicity in yeast cells. Overexpression of SteC resulted in large, 
swollen, and unbudded cells with depolarized actin (Aleman et al., 
2009), resembling the phenotype described for cdc42 or cdc24 
mutant cells (Perez and Rincon, 2010) and consistent with the 
Cdc42-inhibitory function of SteC described here. Thus our results 
suggest that not only the kinase domain, but also the N-terminal 
region of SteC could be modulating the actin cytoskeleton via 
Cdc42. This idea is in agreement with previous observations by Poh 
et al. (2008), who found that full-length SteC induced formation of 
F-actin clusters and cables randomly distributed throughout the cy-
toplasm, whereas in mammalian cells expressing the kinase domain 
alone, these structures were mainly found at the cell periphery. Be-
cause the Rho family of small GTPases comprises important regula-
tors of actin organization (Hall, 1998), targeting these GTPases or 
their regulators is one of the most common mechanisms used by 
bacterial effectors to manipulate cytoskeleton pathways. The mam-
malian GEF Vav1 has been shown to regulate actin cytoskeleton 
changes associated with RhoA, Rac1, and Cdc42 (Olson et al., 
1996). Therefore binding of SteC to Vav1 suggests that this Salmo-
nella effector could be influencing actin dynamics via Vav1. In addi-
tion, Vav1 has been reported to play a role in bacterial lipopolysac-
charide-mediated macrophage activation and nitric oxide synthase 
production (Godambe et al., 2004). The action of SteC on Vav1 
would be also consistent with the function of the Salmonella SPI-2 
in counteracting the nitrosative stress in host macrophages (Das 
et al., 2009).
By expressing SteC in yeast, we have been able to evaluate the 
effect of Cdc42 function on yeast MAPK signaling. As opposed to 
the inhibition of the mating pathway described here, we previ-
ously reported that expression of SteC led to the activation of 
Slt2, the MAPK operating in the CWI pathway (Aleman et al., 
2009). It is likely that the morphogenetic and cell wall alterations 
originating from SteC-induced Cdc42 inhibition leads to a stress 
sensed by the CWI pathway. These results confirm that Cdc42 is 
not directly mediating signal transduction through the CWI path-
way and underscore the role of this GTPase as a key component 
of the mating pathway. Because the CWI pathway is mediated by 
the GTPase Rho1 (Chen and Thorner, 2007), our results also point 
to a specificity of SteC for Cdc42 GEFs in the yeast model. Con-
sistently, we could not detect binding of SteC to the Rho1 GEF 
Rom1 (Perez and Rincon, 2010). Although this GEF shares 23% 
identity with Cdc24 within the DH domain, other regions distinct 
from the DH domain of Rom1 could restrict its binding to SteC, in 
contrast to that occurring for Cdc24. We also show here that sig-
naling induced by pheromone can be reduced to basal levels by 
interfering with the Cdc42 GEF Cdc24, emphasizing its key role 
not only in the morphogenetic changes associated with mating, 
but also in signaling through the MAPK mating pathway. More-
over, signaling inhibition caused by SteC supports the model in 
which two complementary signaling nodes—the Ste5-bound ki-
nases and the Cdc42–Ste20 complex—assemble at the yeast 
plasma membrane to initiate activation of the mating pathway 
(Winters et al., 2005). More broadly, our results show that expres-
sion of bacterial effectors in yeast cells can be exploited to un-
cover novel properties of these proteins, as well as to provide new 
tools to study yeast signaling.
or by modifying the activity of GTPase regulators, as reported for the 
Rho GEF inhibitor EspH from enteropathogenic and enterohemor-
rhagic E. coli (Dong et al., 2010). In the case of SteC, our data indi-
cate that Cdc42 inhibition is likely exerted via binding to its cognate 
GEF. First, overexpression of SteC in yeast cannot suppress the ef-
fect of the constitutively GTP bound mutant Cdc42G12V. Second, 
SteC is able to interact both in vivo and in vitro with Cdc24, the sole 
GEF for this GTPase in yeast, but not with Cdc42. Third, SteC also 
binds to the Cdc24-like GEFs S. pombe Scd1 and human Vav1. 
Fourth, cellular localization of Cdc24 is altered by SteC expression.
The effector EspH has been shown to bind directly the DH do-
main of multiple Rho GEFs, thus preventing their binding to Rho 
and thereby inhibiting nucleotide exchange–mediated Rho activa-
tion (Dong et al., 2010). SteC also interacts with the DH domain of 
GEFs, but it is not able to inhibit in vitro the exchange capacity of 
Vav1, a human GEF that belongs to the Dbl family and contains a 
catalytic DH domain similar to yeast Cdc24. Although it is possible 
that our in vitro assays lacked an essential cofactor required in cells 
to exert the biological effect, the molecular mechanism responsible 
for the action of SteC on the target GEF seems to be different from 
that described for EspH. Inhibition of the exchange activity is not 
the only way to modulate GEF function in eukaryotic cells. For ex-
ample, MLK3 binds to the Rho activator p63RhoGEF, impeding its 
activation by Gαq and thus preventing Rho activation (Swenson-
Fields et al., 2008). Our results suggest that alteration of Cdc24 cel-
lular localization could account for the defect in Cdc42 functionality. 
Cdc24 shuttling between the nucleus and the cytoplasm regulates 
cell polarity (Nern and Arkowitz, 2000; Shimada et al., 2000) due to 
its role in localizing Cdc42 at growth sites (Howell and Lew, 2012). 
Far1 has been shown to be responsible for nuclear sequestration of 
Cdc24 (Nern and Arkowitz, 2000; Shimada et al., 2000). In addition, 
the GTPase Rsr1 seems to be involved not only in Cdc24 targeting 
to the growth site, but also in its activation. However, the fact that 
the double far1Δ rsr1Δ mutant is viable suggests that additional pro-
teins are also involved in recruiting Cdc24 to specific sites at the cell 
cortex (Shimada et al., 2004). Binding to SteC might inhibit the inter-
action of Cdc24 with any of these proteins involved in proper local-
ization of active Cdc24. This hypothesis is consistent with our data 
showing that Rsr1 overexpression partially recovers the growth inhi-
bition imposed by SteC, bearing in mind that overexpression of Rsr1 
rescues the growth defect of a cdc24 mutant unable to interact with 
Rsr1 (Shimada et al., 2004). It is also tempting to speculate that SteC 
could modify Vav1 localization in human cells, since this GEF has 
also been shown to undergo nucleocytoplasmic redistribution 
(Adam et al., 2000; Bertagnolo et al., 2012). Additional experiments 
in mammalian cells are needed to test this possibility.
Expression in yeast provides a convenient way to define the 
functional domains of bacterial effector proteins (Aleman et al., 
2005). According to our results, the N-terminal region of SteC is re-
sponsible for the observed Cdc42 inhibition. The C-terminal, Raf1-
homologous, kinase domain of SteC is necessary for inducing the 
formation of the F-actin meshwork around the Salmonella-contain-
ing vacuole inside host cells (Poh et al., 2008). Therefore our find-
ings suggest that SteC, as with many other bacterial effectors (Dean, 
2011), is composed of functionally distinct domains conforming to a 
modular protein. Salmonella Typhimurium SipA effector is cleaved 
by caspase-3 within the host cell, thereby generating two indepen-
dent active domains (Srikanth et al., 2010). These authors also re-
ported that other caspase-3 sites identified within Salmonella 
Typhimurium proteins appear to be restricted to T3SS translocated 
effectors, which indicates that proteolytic cleavage may be a strat-
egy used by the pathogen for activating effectors delivered in a 
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by PCR amplification from Salmonella Typhimurium SL1344 
genomic DNA, using oligonucleotides described in Supplemental 
Table S2 and cloning in the correct orientation into the correspond-
ing site of pEG(KG) (URA3 GAL1-GST leu2-d 2μ; Mitchell et al., 
1993). Amplified DNA was verified by DNA sequencing.
Screening for suppressors of SteC toxicity
YPH499 strain bearing plasmid YCpLG-SteC for SteC expression 
driven by GAL1 promoter was transformed with a yeast cDNA li-
brary in pYES2 plasmid (kindly provided by Enrique Herrero; Espinet 
et al., 1995) and plated on SG medium in order to select clones able 
to grow in the presence of galactose as carbon source and therefore 
able to suppress the impaired growth of SteC-expressing cells. From 
128,000 clones screened, 20 were selected by this means. Twelve of 
them showed dependence on the pYES2-based plasmid for grow-
ing on galactose, as revealed by plasmid loss and 5-fluoroorotic 
acid counterselection.
Quantitative β-galactosidase assays
β-Galactosidase assays were performed as described (Hao et al., 
2003). Briefly, cells were transformed with plasmid pRS423-FUS1-
lacZ for expression of β-galactosidase under the control of FUS1 
promoter as reporter for mating pathway activation. Overnight cul-
tures were refreshed in SD medium, grown during the day, refreshed 
in SR medium at an OD600 of 0.01, and cultured overnight. Then 
they were refreshed in the same medium at an OD600 of 0.3, and 
galactose was added to a final concentration of 2%. After 3–4 h 
(OD600 of 0.6–0.8), 90 μl of each culture was transferred to a 96-well 
plate and α-factor was added to different final concentrations 
(0, 0.001, 0.003, 0.01, 0.03, 0.1, 0.3, 1, 3, 10, and 30 μM) in a final 
MATERIALS AND METHODS
Bacterial and yeast strains and yeast genetics methods
The S. cerevisiae strains used in this study are listed in Table 1. The 
Salmonella Typhimurium SL1344 strain (Hoiseth and Stocker, 1981) 
used in this study was kindly provided by F. García del Portillo. The 
PPG103 S. pombe strain (h- leu1-32 ura4-D18) was provided by Pilar 
Pérez (Moreno et al., 1991). Standard procedures were used for 
yeast genetic manipulations (Sherman, 1991). Yeast transformations 
were performed with the lithium acetate method (Ito et al., 1983).
Culture conditions
YPD (1% yeast extract, 2% peptone, and 2% glucose) broth or agar 
was the complete medium used for growing the yeast strains. Syn-
thetic medium (SD) contained 0.17% yeast nitrogen base without 
amino acids and ammonium sulfate, 0.5% ammonium sulfate, and 
2% glucose and was supplemented with appropriate amino acids 
and nucleic acid bases (Sherman, 1991). SG and SR were SD with 
2% galactose or raffinose, respectively, instead of glucose. Galac-
tose induction experiments in liquid media were performed by 
growing cells in SR medium to log phase, then adding galactose to 
2% for the indicated time. The effects of the overexpression of dis-
tinct proteins on yeast growth were tested by spotting cells onto SD 
or SG plates. Briefly, transformants were grown in liquid SD medium 
at 24ºC to an OD600 of 0.5, and 5 μl of a 10-fold dilution series of this 
culture was spotted onto the indicated plates.
DNA manipulation and plasmids
General DNA methods were used, using standard techniques 
(Sambrook et al., 1989). The steC-containing plasmids used in this 
study are described in Supplemental Table S1 and were constructed 
Strain Genotype Source
YPH499 MATa ade2-101 trp1-63 leu2-1 ura3-52 his3-Δ200 lys2-801 P. Hieter (British Columbia University, Vancouver, Canada)
YDM400 MATa ade2-101 trp1-63 leu2-1 ura3-52 his3-Δ200 lys2-801 
sst2-Δ2
H. Dohlman (North Carolina University, Chapel Hill, NC)
BY4741 MATa his3Δ1 leu2Δ met15Δ ura3Δ EUROSCARF
Y04500 MATα his3Δ1 leu2Δ met15Δ ura3Δ, itc1::kanMX4 EUROSCARF
Y01268 BY4741 isogenic, far1::kanMX4 EUROSCARF
Y02724 BY4741 isogenic hog1::kanMX4 EUROSCARF
Y03340 BY4741 isogenic, ste50::kanMX4 EUROSCARF
Y03439 BY4741 isogenic, bem1::kanMX4 EUROSCARF
Y03857 BY4741 isogenic ste7::kanMX4 EUROSCARF
Y00993 BY4741 isogenic slt2::kanMX4 EUROSCARF
Y06981 BY4741 isogenic kss1::kanMX4 EUROSCARF
Y03042 BY4741 isogenic fus3::kanMX4 EUROSCARF
TM141 MATa leu2 ura3 trp1 his3 Alonso-Monge et al. (2001)
TM257 MATα ura3 leu2 trp1 his3 ssk2::LEU2 ssk22::LEU2 Raitt et al. (2000)
BYgpa1 BY4741 isogenic gpa1::kanMX4 H. Martín (Complutense University, Madrid, Spain)
RAY1773 MATa leu2-3,-112 ura3-52 trp1-1 ade2-1 his3-11 can1-100 
GAL bar1 cdc24×3HA::Klactis URA
Mionnet et al. (2008)
YKT725 MATa cdc24Δ::KanMX6 ura3-52 his3Δ-200 trp1Δ-63 
leu2Δ-1 lys2-801 pKT1154 (pRS415-Cdc24p-GFP-CDC24)
Fujimura-Kamada et al. (2012)
EUROSCARF, European Saccharomyces cerevisiae Archive for Functional Analysis, Institute for Molecular Biosciences, Johann Wolfgang Goethe-University Frankfurt, 
Frankfurt, Germany.
TABLE 1: S. cerevisiae strains used in this work.
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Immunoprecipitation assays
To analyze Cdc24 oligomerization, RAY1773 yeast cells express-
ing HA-tagged Cdc24 transformed with p414-3xmycCdc24Fl 
plasmid for expression of myc-tagged Cdc24 and pEG(KG)H, 
pEG(KG)H-SteC, or pEG(KG)H-SteC1-229 were lysed in the same 
buffer used in copurification assays. Dynabeads PanMouse immu-
noglobulin G (Invitrogen, Carlsbad, CA), 25 μl/sample, was incu-
bated with anti-HA.11 antibody (clone 16B12; Covance) at a dilu-
tion of 1:150 for 2–3 h at 4ºC. After washing with PBS and 0.1% 
bovine serum albumin, cell extracts were added and the mixture 
was incubated for 3–4 h. Then, beads were washed three times, 
eluted by boiling in 30 μl of 2× SDS–PAGE sample loading buffer, 
and assayed by Western blotting with anti-myc and anti-HA 
antibodies.
Guanine nucleotide exchange assays
In vitro guanine nucleotide exchange was carried out essentially as 
described previously (Rojas et al., 2003). For loading reactions, 
400 nM Rac1 and 80 nM Bodipy FL GDP were incubated in 1 ml of 
buffer consisting of 20 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 
5% (vol/vol) glycerol, 2 mM DTT, and 0.08% (vol/vol) NP-40, and 
fluorescence (λex = 502 nm; λem = 511 nm) was monitored with a 
PerkinElmer LS55 spectrofluorometer (slits, 2.5 nm) thermostatted 
to 15°C. At the indicated time, 4 μl of a stock solution consisting of 
1.25 μM Vav1 (DH/PH/CRD fragment; Chrencik et al., 2008) either 
alone or preincubated for 5 min with 12.5 μM SteC, was added, re-
sulting in final concentrations of 5 nM Vav1 and 50 nM SteC. Un-
loading reactions were carried out similarly, except that Rac1 was 
preloaded with Bodipy FL GDP and incubated with 20 μM GDP 
before additions of Vav1 and SteC, resulting in final concentrations 
of 10 and 100 nM, respectively.
Microscopy and immunofluorescence
Fluorescence microscopy of live yeast cells for GFP detection was 
performed as described (Rodriguez-Escudero et al., 2006). Cells 
harboring GFP fusion vectors with MET25 promoter were cultured 
overnight in selective SD medium and then washed three times 
with sterile water and refreshed in the same medium lacking me-
thionine. After 6 h at 30ºC cell suspensions were spotted on slides 
for microscopy observation. For FM4-64 staining, cells were 
pelleted, resuspended in the same medium containing 40 μM 
FM4-64, and incubated for 1 h at 30ºC. Differential interference 
contrast (DIC) images were acquired by using an Eclipse TE2000U 
microscope (Nikon, Melville, NY) fitted with an Orca C4742-
95-12ER digital camera (Hamamatsu, Hamamatsu, Japan) and 
then processed by using Aquacosmos Imaging System software 
(Hamamatsu).
volume of 100 μl. Plates were incubated at 30 ºC for 90 min, and 
20 μl of FDG solution (130 mM 1,4-piperazinediethanesulfonic acid, 
pH 7.2, 0.25% Triton X-100, 0.5 mM fluorescein-di-β-
galactopyranoside) was added. Plates were incubated at 37ºC for 
1 h, and reaction was stopped by adding 20 μl of NaHCO3, 1 M, 
before measuring the fluorescence signal in a PerkinElmer fluori-
meter (PerkinElmer, Waltham, MA).
Preparation of yeast extracts and immunoblot analysis
The procedures used have been previously described (Martin et al., 
2000). Immunodetection of actin and Myc-tagged proteins was car-
ried out using monoclonal C4 (IMP Biomedicals, Santa Ana, CA) and 
9E10 (Covance, Berkeley, CA) antibodies, respectively. Anti–phospho-
p44/p42 MAPK (Thr-202/Tyr-204), anti–phospho-p38 MAPK (Thr-180/
Tyr-182; Cell Signaling, Beverly, MA), anti-GST (Santa Cruz Biotech-
nology, Santa Cruz, CA), anti-TAP (Open Biosystems, Huntsville, AL), 
anti-His (Sigma-Aldrich, St. Louis, MO), anti–glucose-6-phosphate de-
hydrogenase (G6PDH) antibodies (Sigma-Aldrich), anti-GFP Jl-8 
(Clontech, Mountain View, CA) and anti-HA (Roche, Indianapolis, IN) 
antibodies were also used. The primary antibodies were detected ei-
ther using a horseradish peroxidase–conjugated secondary antibody 
with the ECL detection system (Amersham, Piscataway, NJ) or a fluo-
rescently conjugated secondary antibody with an Odyssey Infrared 
Imaging System (LI-COR Biosciences, Lincoln, NE).
Expression of recombinant proteins in E. coli and 
preparation of extracts
Recombinant GST- or histidine-tagged proteins were expressed 
from pGEX-KG or in E. coli strain Rosetta DE3 (Novagen, 
Gibbstown, NJ). Cells were collected and lysed by sonication in 
phosphate-buffered saline (PBS) buffer containing 2 mM phenyl-
methylsulfonyl fluoride, 1 mM dithiothreitol (DTT), 1 mM EDTA, 
and 1 mg/ml lysozyme in the presence of protease inhibitor cock-
tail (Roche). Extracts were clarified by centrifugation and then 
stored at −80ºC.
Copurification assays
For in vivo binding assays, yeast cells were resuspended in lysis buf-
fer lacking SDS and Triton X-100 and broken with glass beads in a 
Fast Prep machine. Samples were adjusted to a final volume of 
200 μl. Then, 100 μl of 50% slurry of glutathione-Sepharose 4B resin 
in lysis buffer was added and incubated on a roller for 3–12 h at 4ºC. 
Beads, recovered by brief centrifugation, were then washed five 
times in lysis buffer and subsequently resuspended in 30 μl of 2× 
SDS–PAGE sample loading buffer. Bound proteins were eluted by 
boiling for 10 min. After centrifugation at 13,200 rpm for 15 s, the 
resulting supernatant was resolved by SDS–PAGE, transferred to ni-
trocellulose, and processed for immunoblotting. For in vivo binding 
assays to Gpa1, yeast cells were resuspended in 250 μl of the cor-
responding lysis buffer (40 mM triethanolamine, pH 7.2, 2 mM 
EDTA, 150 mM NaCl, 2 mM DTT, 3 mM MgCl2, and protease inhibi-
tors) and broken with glass beads in a Fast Prep machine. Lysates 
were cleared by centrifugation at 3200 rpm twice for 10 min each, 
and 1.5% Triton X-100 was added to the resulting supernatant solu-
tion for 1 h. Then the insoluble material was removed by centrifuga-
tion at 13,200 rpm for 10 min. Samples were then processed in the 
same way as described previously.
In vitro binding assays were performed by binding GST or 
GST-fused proteins from E. coli extracts to glutathione-Sepharose 
4B resin, and then either E. coli or yeast extracts bearing the 
corresponding tagged proteins were added and processed as 
described.
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